FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3119512223> ?p ?o ?g. }

• W3119512223 endingPage "661" @default.
• W3119512223 startingPage "661.2" @default.
• W3119512223 abstract "Background: Although guidelines do not recommend antiphospholipid antibodies testing after 60 yo, recent data reported late onset antiphospholipid syndrome (APS). Objectives: To comparatively analyse the clinical, laboratory features and outcomes in 695 cases with primary APS between patients older and younger than 70 yo. Methods: we have performed an international study within the framework of the International Registry of primary APS patients treated with Hydroxychloroquine, HIBISCUS (an ongoing retrospective and prospective register launched in 2016). 28 centres from 17 countries participate. Data about late onset APS were analysed in 695 patients and were obtained from a standardized form registered in the database containing 66 items with respect to demographics, clinical and biological features. Results: Arterial events and especially stroke represented the main initial and recurrent clinical manifestation in 40 primary APS patients older than 70 yo. There were not statistically significant differences with respect to cardiovascular risk factors between the two groups of patients. A significant male predominance, a familial APS history, a higher prevalence of triple positivity, lower complement levels, and anticardiolipin antibodies (aCL) IgA isotype were found in older patients. Low anticoagulation regimens were safe and efficient, with a low relapse rate in older patients. Conclusion: we suggest that the detection of aPL antibodies should be included into the initial screening panel tests in elderly with thrombotic events, especially arterial, in particular those with recurrent stroke and familial APS. Our study further suggests that lower intensity anticoagulation regimens could be a therapeutic option in older APS patients, as no differences in outcomes and relapse rate were found between patients with high and low intensity anticoagulation regimens. References: [1]Grimaud F et al. Rheumatology. 2019;58:1006-10. [2]Goldman-Mazur S et al. Thromb Res. 2019;176:67-73. [3]Hirmerova J et al. 2017;36:167-73. Disclosure of Interests: Cristina Belizna: None declared, Omar Latino: None declared, Ljudmila Stojanovich: None declared, Patrick Saulnier: None declared, Katrien Devreese: None declared, Sebastien Udry: None declared, Natasa Stanisavljevic: None declared, Aleksandra Djokovic Speakers bureau: KRKA, Astra Zeneca, Actavis, Jaume Alijotas-Reig: None declared, Enrique Esteve-Valverde: None declared, Raquel Ferrer-Oliveras: None declared, Angela Tincani: None declared, Laura Andreoli: None declared, Francesca Regola: None declared, Maarten Limper: None declared, Alexander Makatsariya: None declared, Jamilya Khizroeva: None declared, Viktoria Bitsadze: None declared, Cecilia Chighizola: None declared, Francesca Pregnolato: None declared, Maria Orietta Borghi: None declared, Pier Luigi Meroni: None declared" @default.
• W3119512223 created "2021-01-18" @default.
• W3119512223 creator A5004705984 @default.
• W3119512223 creator A5007350571 @default.
• W3119512223 creator A5009981315 @default.
• W3119512223 creator A5019339083 @default.
• W3119512223 creator A5019743703 @default.
• W3119512223 creator A5025542652 @default.
• W3119512223 creator A5038863992 @default.
• W3119512223 creator A5039168250 @default.
• W3119512223 creator A5044427028 @default.
• W3119512223 creator A5054867181 @default.
• W3119512223 creator A5056105834 @default.
• W3119512223 creator A5057987159 @default.
• W3119512223 creator A5058303256 @default.
• W3119512223 creator A5061119590 @default.
• W3119512223 creator A5063377000 @default.
• W3119512223 creator A5071705224 @default.
• W3119512223 creator A5079447134 @default.
• W3119512223 creator A5079672940 @default.
• W3119512223 creator A5083016749 @default.
• W3119512223 creator A5083878563 @default.
• W3119512223 creator A5085671931 @default.
• W3119512223 creator A5086576456 @default.
• W3119512223 date "2020-06-01" @default.
• W3119512223 modified "2023-09-26" @default.
• W3119512223 title "FRI0154 SHOULD BE OLDER PATIENTS TESTED FOR ANTIPHOSPHOLIPID ANTIBODIES? 695 CASES FROM THE RETROSPECTIVE SERIES HIBISCUS" @default.
• W3119512223 doi "https://doi.org/10.1136/annrheumdis-2020-eular.6417" @default.
• W3119512223 hasPublicationYear "2020" @default.
• W3119512223 type Work @default.
• W3119512223 sameAs 3119512223 @default.
• W3119512223 citedByCount "1" @default.
• W3119512223 countsByYear W31195122232023 @default.
• W3119512223 crossrefType "journal-article" @default.
• W3119512223 hasAuthorship W3119512223A5004705984 @default.
• W3119512223 hasAuthorship W3119512223A5007350571 @default.
• W3119512223 hasAuthorship W3119512223A5009981315 @default.
• W3119512223 hasAuthorship W3119512223A5019339083 @default.
• W3119512223 hasAuthorship W3119512223A5019743703 @default.
• W3119512223 hasAuthorship W3119512223A5025542652 @default.
• W3119512223 hasAuthorship W3119512223A5038863992 @default.
• W3119512223 hasAuthorship W3119512223A5039168250 @default.
• W3119512223 hasAuthorship W3119512223A5044427028 @default.
• W3119512223 hasAuthorship W3119512223A5054867181 @default.
• W3119512223 hasAuthorship W3119512223A5056105834 @default.
• W3119512223 hasAuthorship W3119512223A5057987159 @default.
• W3119512223 hasAuthorship W3119512223A5058303256 @default.
• W3119512223 hasAuthorship W3119512223A5061119590 @default.
• W3119512223 hasAuthorship W3119512223A5063377000 @default.
• W3119512223 hasAuthorship W3119512223A5071705224 @default.
• W3119512223 hasAuthorship W3119512223A5079447134 @default.
• W3119512223 hasAuthorship W3119512223A5079672940 @default.
• W3119512223 hasAuthorship W3119512223A5083016749 @default.
• W3119512223 hasAuthorship W3119512223A5083878563 @default.
• W3119512223 hasAuthorship W3119512223A5085671931 @default.
• W3119512223 hasAuthorship W3119512223A5086576456 @default.
• W3119512223 hasBestOaLocation W31195122231 @default.
• W3119512223 hasConcept C126322002 @default.
• W3119512223 hasConcept C127413603 @default.
• W3119512223 hasConcept C144024400 @default.
• W3119512223 hasConcept C149923435 @default.
• W3119512223 hasConcept C167135981 @default.
• W3119512223 hasConcept C187212893 @default.
• W3119512223 hasConcept C2776874634 @default.
• W3119512223 hasConcept C2779123688 @default.
• W3119512223 hasConcept C2779134260 @default.
• W3119512223 hasConcept C2780084366 @default.
• W3119512223 hasConcept C2780645631 @default.
• W3119512223 hasConcept C2780868729 @default.
• W3119512223 hasConcept C2781179581 @default.
• W3119512223 hasConcept C3008058167 @default.
• W3119512223 hasConcept C524204448 @default.
• W3119512223 hasConcept C71924100 @default.
• W3119512223 hasConcept C78519656 @default.
• W3119512223 hasConceptScore W3119512223C126322002 @default.
• W3119512223 hasConceptScore W3119512223C127413603 @default.
• W3119512223 hasConceptScore W3119512223C144024400 @default.
• W3119512223 hasConceptScore W3119512223C149923435 @default.
• W3119512223 hasConceptScore W3119512223C167135981 @default.
• W3119512223 hasConceptScore W3119512223C187212893 @default.
• W3119512223 hasConceptScore W3119512223C2776874634 @default.
• W3119512223 hasConceptScore W3119512223C2779123688 @default.
• W3119512223 hasConceptScore W3119512223C2779134260 @default.
• W3119512223 hasConceptScore W3119512223C2780084366 @default.
• W3119512223 hasConceptScore W3119512223C2780645631 @default.
• W3119512223 hasConceptScore W3119512223C2780868729 @default.
• W3119512223 hasConceptScore W3119512223C2781179581 @default.
• W3119512223 hasConceptScore W3119512223C3008058167 @default.
• W3119512223 hasConceptScore W3119512223C524204448 @default.
• W3119512223 hasConceptScore W3119512223C71924100 @default.
• W3119512223 hasConceptScore W3119512223C78519656 @default.
• W3119512223 hasIssue "Suppl 1" @default.
• W3119512223 hasLocation W31195122231 @default.
• W3119512223 hasOpenAccess W3119512223 @default.
• W3119512223 hasPrimaryLocation W31195122231 @default.
• W3119512223 hasRelatedWork W1985670370 @default.
• W3119512223 hasRelatedWork W2017882825 @default.
• W3119512223 hasRelatedWork W2072799582 @default.

• next